XML 55 R5.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities:    
Net loss $ (36,572,200) $ (6,574,200)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 28,900 26,200
Amortization of discounts on convertible and promissory notes 564,800 799,000
Change in warrant liability 1,894,700 425,400
Stock-based compensation 3,769,900 $ 408,400
Expense related to modification of warrants 122,300
Non-cash rent expense $ (11,600) $ (5,000)
Interest income on note receivable for stock purchase 1,700
Fair value of common stock granted for services $ 500,000 $ 134,000
Fair value of Series B Preferred stock granted for services $ 707,500
Fair value of warrants granted for services and interest $ 29,900
Foreign currency transaction gain $ (6,300) (200)
Loss on extinguishment of debt 26,700,200 2,371,400
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 24,200 (52,100)
Accounts payable and accrued expenses, including accrued interest (51,900) 902,100
Net cash used in operating activities $ (2,329,500) $ (1,533,400)
Cash flows from investing activities:    
Purchases of equipment, net
Net cash used in investing activities
Cash flows from financing activities:    
Net proceeds from issuance of common stock and warrants, including Units $ 280,000 $ 1,730,200
Net proceeds from issuance of Series B Preferred Units 2,722,800
Repayment of capital lease obligations (500) $ (3,500)
Repayment of notes (48,800) (193,300)
Net cash provided by financing activities 2,953,500 $ 1,533,400
Net increase in cash and cash equivalents 624,000
Cash and cash equivalents at beginning of period 70,000
Cash and cash equivalents at end of period 694,000
Supplemental disclosure of noncash activites:    
Senior Secured Notes, 2014 Unit Notes, other promissory notes and related accrued interest, and accounts payable, including conversion premiums, converted into Series B Preferred stock $ 18,891,400